GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Institutional Ownership

Nextbiomedical Co (XKRX:389650) Institutional Ownership : 9.69% (As of May. 07, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nextbiomedical Co's institutional ownership is 9.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nextbiomedical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nextbiomedical Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Nextbiomedical Co Institutional Ownership Historical Data

The historical data trend for Nextbiomedical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextbiomedical Co Institutional Ownership Chart

Nextbiomedical Co Historical Data

The historical data trend for Nextbiomedical Co can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30
Institutional Ownership 1.08 4.55 5.85 5.11 8.72 9.05 9.26 9.69 9.69

Nextbiomedical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Nextbiomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Nextbiomedical Co Headlines

No Headlines